Andrographis paniculata - Nestlé has high hopes for its digestive system prowess in 2014 but will conduct clinicals first

Related tags:
Andrographis paniculata, Nutrition, Herbal

Nestlé has amplified its nutrition presence by forming a joint venture to develop Traditional Chinese Medicines (TCM). Orally consumed gastro products will be first off the rank based on an extract from the andrographis paniculata plant grown in Indian and Sri Lanka.

Spokesperson Hilary Green said the extract - HMPL-004 - "is not on the market as yet as phase III trials have not yet been approved by the US Food and Drug Administration (FDA)."

Expansion could occur into metabolic disease and brain health; president and CEO of Nestlé Health Science, Luis Cantarell, said clinical trials would commence in 2013 utilising HMPL-004.

Supplement products already formulate with andrographis paniculata with one claiming it supported, “digestive, cardiovascular and urinary systems” and contained, “andrographolide, deoxyandrographolide and neoandrographolide,5,7, tetramethoxyflavanone and 5-hydroxy-7, trimethoxyflavone, as well as several other flavonoids and polyphenols.”

Nestlé’s new partner is Hong Hong-based, Hutchison Whampoa-owned Chi-Med, which has a bank of 50,000 extracts and 1200 plants – a bank that Nestlé will be keen to tap going forward.

"a major acceleration in our quest to expand the boundaries of nutrition”

Cantarell said the new joint venture – called Nutritional Science Partners – “represents a major acceleration in our quest to expand the boundaries of nutrition”.

A product could reach shelves by 2014, in the form of an, “oral therapy extracted from a herb used in TCM to address mild to moderate inflammatory bowel disease.”

It is not clear if the product will be a supplement or a drug – or which markets it may launch in.

Chi-Med CEO Christian Hogg added: “We are joined in this important endeavour by Nestlé Health Science, and are confident that by harnessing the resources of our two groups, we will succeed in bringing a stream of novel botanical medicines and nutritional products to market and in-so-doing build significant value for patients and for our shareholders.”

Expanding nutrition portfolio

The 50/50 joint venture will begin with an undisclosed capital investment from Nestlé.

Since Nestlé Health Science was established in 2011 it has made several acquisitions to aid its quest to explore the food-pharma divide including US gastrointestinal diagnostics company Prometheus, New Zealand-based Vital Foods
and UK-based CM&D Pharma Ltd.

Nestlé has amplified its nutrition presence by forming a joint venture to develop Traditional Chinese Medicines (TCM). Orally consumed gastro products will be first off the rank based on an extract from the andrographis paniculata plant grown in Indian and Sri Lanka.

Clinical study

18-Mar-2015 - Obesity and overweight are considered to be major risk factors for a number of metabolic diseases such as diabetes, hypertension and cardiovascular diseases, leading to reduced life expectancy. Therapeutic weight loss includes a combination of diet, exercise and behaviour modification,...

Clinical study

18-Mar-2015 - Nourish the skin from the inside out withPycnogenol®, French maritime pine bark extract.Decades of research on Pycnogenol® have shown it effectively improves visible signs of aging by improving skin hydration and elasticity, reduces the appearance of over-pigmentation and skin inflammation....

Technical / white paper

17-Mar-2015 - Inflammation affects heart health, arthritis and many other health issues – and growing evidence suggests that nutrition is part of the solution. Seize this opportunity with custom nutrient premixes.Any nutrient. Any application. Anywhere in the world.

Data sheet

16-Mar-2015 - KinOmegaTM TGN Omega-3 EPA/DHA Fatty Acids concentrates are produced through the Proprietary Enzymatic Process with the combination of unique Three-time Molecular Distillation purification technology. It is the improved generation and high quality Omega-3 EPA/DHA TG concentrates with high TG (Triglycerides...

Application note

23-Feb-2015 - Polaris has developed an innovative formulation containing ultra-concentrated marine oil Omega 3 stabilised with Qualitysilver® technology, helping to reach EFSA health claims with only 1 capsule a day. Take a closer look at this product for various health benefits: Brain...

Data sheet

12-Feb-2015 - Innovative ability is one of the most important competitive factors for small to medium-sized food companies to stay at the forefront in the dynamic and challenging supplement market. An innovative product idea could be the key advantage. If you don't...

Data sheet

09-Feb-2015 - AstaPure® is natural Astaxanthin from Haematococcus pluvialis. Our partner Algatechnologies employs a closed tubular and environmentally-protected cultivation system for the production of its natural astaxanthin AstaPure®. This technology allows for a highly controlled cultivation system, eliminating the introduction of foreign...